First Trust Advisors LP Tg Therapeutics, Inc. Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 28,351 shares of TGTX stock, worth $826,148. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,351

Previous 156,828 81.92%

Holding current value

$826,148

Previous $2.79 Million 76.23%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$17.21 - $25.28 $2.21 Million - $3.25 Million	-128,477 Reduced 81.92%	28,351 $663,000
Q2 2024 Aug 13, 2024	SELL	$13.32 - $19.19 $156,296 - $225,175	-11,734 Reduced 6.96%	156,828 $2.79 Million
Q1 2024 May 13, 2024	BUY	$13.02 - $21.3 $1.69 Million - $2.77 Million	129,995 Added 337.06%	168,562 $2.56 Million
Q4 2023 Feb 13, 2024	SELL	$6.68 - $18.81 $689,462 - $1.94 Million	-103,213 Reduced 72.8%	38,567 $658,000
Q3 2023 Nov 13, 2023	SELL	$8.36 - $26.5 $141,852 - $449,652	-16,968 Reduced 10.69%	141,780 $1.19 Million
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $2.46 Million - $5.56 Million	158,748 New	158,748 $3.94 Million
Q4 2021 Feb 08, 2022	SELL	$15.2 - $35.51 $330,144 - $771,277	-21,720 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$21.78 - $40.45 $487,959 - $906,241	-22,404 Reduced 50.78%	21,720 $723,000
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $1.16 Million - $1.75 Million	-35,656 Reduced 44.69%	44,124 $1.71 Million
Q1 2021 May 14, 2021	BUY	$41.61 - $54.3 $244,916 - $319,609	5,886 Added 7.97%	79,780 $3.85 Million
Q4 2020 Feb 02, 2021	SELL	$25.27 - $54.9 $196,499 - $426,902	-7,776 Reduced 9.52%	73,894 $3.84 Million
Q3 2020 Nov 05, 2020	SELL	$18.49 - $27.24 $490,724 - $722,949	-26,540 Reduced 24.53%	81,670 $2.19 Million
Q2 2020 Jul 22, 2020	BUY	$8.9 - $21.84 $963,069 - $2.36 Million	108,210 New	108,210 $2.11 Million

Others Institutions Holding TGTX

# of Institutions

336

Shares Held

87.6M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.23B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Tg Therapeutics, Inc. Transaction History